logo
It pays to turn on the waterworks…but only if you're a man: 'Crocodile tears' are more believable from MEN, study finds - here's how to spot them

It pays to turn on the waterworks…but only if you're a man: 'Crocodile tears' are more believable from MEN, study finds - here's how to spot them

Daily Mail​5 days ago
Whether it's forgetting to do the washing up, or accidentally buying an awful birthday present, there are often times when men annoy their partners.
But if you're in the bad books, then scientists have simple solution for you - turn on the waterworks.
A new study has shown that so-called 'crocodile tears' are more believable when they come from men than from women.
Researchers asked thousands of participants to look at photographs that had been edited to appear tearful.
The faces varied in how much warmth they conveyed, with both male and female faces included.
People were asked to share their perceptions of the faces and how 'honest' they thought the tears were.
Analysis revealed crocodile tears were most believable from people least expected to cry.
This was mainly men, as well as women who ranked lower for 'warmth'.
Writing in the journal Plos One the team, from the University of Lodz in Poland, said: 'Emotional tears have been considered honest and sincere signals, most likely because they are difficult to shed on demand.
'At the same time, people acknowledge that tears can be strategically used to manipulate others - so-called crocodile tears.
'Hence, the question arises under what circumstances tears are perceived as honest signals and when as crocodile tears.'
They explained their results show that tears are not universally seen as 'sincere' because it depends on who is crying and in what situation.
'Most importantly, we found that tears might be more socially beneficial when shed by people less expected to do so - for instance, by men or low-warmth people,' they added.
'Possibly, when men or low-warmth people tear up, which is quite unexpected, observers assume that there must be a genuine reason to do so.'
Previous research has provided clues on how to spot crocodile tears from the real thing.
Scientists found that those who fake remorse show a greater range of emotional expressions and swing from one emotion to the other very quickly - a phenomenon known as 'emotional turbulence'.
People faking remorse also speak with more hesitation, they found.
The phrase 'crocodile tears' comes from an old myth that the large reptiles cry while eating.
To determine whether there was any truth to this, researchers carried out experiments which involved feeding captive caimans and alligators.
They found that crocodiles really do bawl while banqueting - but for physiological reasons rather than from feeling sad.
The team said they believe the tears may occur as a result of the animals hissing and huffing, a behaviour that often accompanies feeding.
Air forced through the sinuses may trigger tear ducts, which empty into the eye, they said.
Where did the phrase 'crocodile tears' come from?
Saying that someone is crying 'crocodile tears' indicates they're faking their remorse.
The phrase stems from the idea that the reptiles cry when they tear the meat off their prey.
The idea even appears in the 14th century book 'The Travels of Sir John Mandeville,' which documents a knight's travels throughout the globe.
'In that country be a general plenty of crocodiles...These serpents slay men and they eat them weeping,' a passage from the book reads.
The idea that the reptiles shed tears while eating was proven by a researcher at the University of Florida's Zoology department.
Analysis of four captive caimans and three alligators found that five out of seven reptiles welled up while eating, with their eyes foaming and gushing.
This is likely triggered by their hissing and puffing, which is a common habit while eating.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Scientists are BAFFLED after discovering a mysterious new structure hiding inside human cells
Scientists are BAFFLED after discovering a mysterious new structure hiding inside human cells

Daily Mail​

timean hour ago

  • Daily Mail​

Scientists are BAFFLED after discovering a mysterious new structure hiding inside human cells

Scientists have discovered a mysterious new structure lurking inside every human cell. These tiny structures, dubbed hemifusomes, are just 200 to 400 nanometres in diameter. To put that into perspective, that's about 500 times thinner than a human hair. Scientists believe the structures play a critical role in helping our cells recycle and discard waste materials. Co-author Dr Seham Ebrahim, of the University of Virginia, says: 'It's exciting because finding something truly new inside cells is rare - and it gives us a whole new path to explore. 'This is like discovering a new recycling centre inside the cell. 'We think the hemifusome helps manage how cells package and process material, and when this goes wrong, it may contribute to diseases that affect many systems in the body.' In the future, the finding could help scientists to develop treatments for conditions such as Hermansky-Pudlak syndrome - a rare genetic disorder that can cause albinism, vision problems, and lung disease. Since hemifusomes are exceptionally small, the researchers needed extremely sensitive equipment to spot them. The team used a method called cryo-electron tomography, in which samples are rapidly frozen to around -150°C (-240°F) before being sliced very thinly. The scientists then took lots of photos with a powerful microscope which uses electrons instead of visible light. This allowed them to look at extremely small structures just as they would appear in a living cell by freezing them in time, rather than damaging the samples by trying to preserve them. Using this method, a team of researchers from the University of Virginia spotted structures which looked like two thin bubbles stuck together at the edges. The researchers believe hemifusomes produce vesicles - tiny sacs that act as 'mixing bowls', as well as making structures made of lots of these vesicles. Dr Ebrahim says: 'You can think of vesicles like little delivery trucks inside the cell. 'The hemifusome is like a loading dock where they connect and transfer cargo. It's a step in the process we didn't know existed.' By placing vesicles inside themselves, hemifusoles can store and combine different chemicals and waste products. Scientists think that some diseases might be caused when this process is disrupted By building vesicles, and even putting vesicles inside each other, the hemifusomes allow our cells to package and sort proteins or recycle parts of the cell. One thing that the researchers were surprised to find is that the layer which connects the hemifusome and the vesicles is much thinner than scientists previously thought possible. This 'hemifusion diaphragm' sticks to the two structures together but doesn't let their contents mix, like two water balloons that have melted together at the edges. Previously, scientists thought these types of structures would be too unstable to do anything useful in our cells. But in the hemifusome, the researchers spotted them playing a really important role in keeping our cells healthy. That discovery could have big implications for how we understand and treat diseases which interfere with our cells' recycling functions. Dr Ebrahim says: 'We're just beginning to understand how this new organelle fits into the bigger picture of cell health and disease. 'Now that we know hemifusomes exist, we can start asking how they behave in healthy cells and what happens when things go wrong. That could lead us to new strategies for treating complex genetic diseases. Cells in numbers Scientists believe the first known cells originated on Earth 3.8 billion years ago. The diameter in centimeters of most animal cells is 0.001 to 0.003, making them invisible to the naked eye. In 1665, British scientist Robert Hooke coined the term cell to describe the porous, grid-like structure he saw when viewing a thin slice of cork under a microscope. There are 200 different types of cells are in the human body. There are 24 hours in an animal cell cycle, the time from a cell's formation to when it splits in two to make more cells. A human red blood cells lives about 120 days. Each day, approximately 50 to 70 billion cells die in the human.

Two NHS drugs slows and could REVERSE devastating Alzheimer's, ‘exciting' study finds
Two NHS drugs slows and could REVERSE devastating Alzheimer's, ‘exciting' study finds

The Sun

timean hour ago

  • The Sun

Two NHS drugs slows and could REVERSE devastating Alzheimer's, ‘exciting' study finds

TWO NHS drugs could be combined to treat, and even reverse, the most common form of dementia, scientists claim. A pair of cancer drugs have been identified as a powerful duo that may tackle Alzheimer's disease, after scientists sifted through 1,300 approved medicines. 1 The American team used cutting-edge computer tools to match the gene changes seen in Alzheimer's patients with medicines that reverse those effects. They found that two cancer drugs, both already available on the NHS, reduced brain degeneration in mice with the disease, and even brought back their memory. The study, from the University of California, San Francisco (UCSF), first looked at how Alzheimer's alters the activity of individual brain cells. They then searched for existing drugs that trigger the opposite changes, with the aim of rewiring damaged neurons and brain cells called glia. And when they tested the top two candidates, letrozole and irinotecan, in lab mice, the results were impressive. One theory of how Alzheimer's comes about is that sticky proteins - like amyloid-beta - start clumping together in the brain years before symptoms appear. These toxic clumps block communication between brain cells and trigger inflammation, eventually causing the cells to die. Some scientists believe this buildup is the root cause of Alzheimer's, so clearing it could stop the disease in its tracks. When combined, the cancer drugs not only halted brain cell damage but also undid toxic clumps of proteins, restored memory and reversed the disease's genetic footprint. Prof Marina Sirota, senior author, said: 'We're excited that our computational approach led us to a potential combination therapy for Alzheimer's based on existing FDA-approved medications.' She added: 'Alzheimer's disease comes with complex changes to the brain, which has made it tough to study and treat — but our tools opened up the possibility of tackling that complexity directly.' The scientists then trawled through the anonymised medical records of 1.4million over-65s and found those already taking the cancer drugs were less likely to develop Alzheimer's. Dr Yaqiao Li, the study's lead author, said: 'Thanks to all these existing data sources, we went from 1,300 drugs, to 86, to 10, to just five. 'In particular, the rich data collected by all the UC health centres pointed us straight to the most promising drugs. It's kind of like a mock clinical trial.' Letrozole is typically used to treat breast cancer, while irinotecan is prescribed for colon and lung cancer. Both are already used in the UK. 'So exciting' Prof Yadong Huang, co-senior author, said: 'Alzheimer's is likely the result of numerous alterations in many genes and proteins that, together, disrupt brain health. 'This makes it very challenging for drug development - which traditionally produces one drug for a single gene or protein that drives disease.' He added: 'It's so exciting to see the validation of the computational data in a widely used Alzheimer's mouse model.' The breakthrough, published in the journal Cell, could fast-track trials in humans. Prof Sirota said: 'If completely independent data sources, such as single-cell expression data and clinical records, guide us to the same pathways and the same drugs and then resolve Alzheimer's in a genetic model then maybe we're onto something.' She added: 'We're hopeful this can be swiftly translated into a real solution for millions of patients with Alzheimer's.' Alzheimer's causes a relentless decline in cognition, learning, and memory. But decades of research have only produced two FDA-approved drugs, neither of which can meaningfully slow the decline. In the UK, no disease-modifying drugs are currently approved or available. Instead, the UK relies on symptom-managing drugs, such as Donepezil and Rivastigmine. Is it ageing or dementia? Dementia - the most common form of which is Alzheimer's - comes on slowly over time. As the disease progresses, symptoms can become more severe. But at the beginning, the symptoms can be subtle or mistaken for normal memory issues related to ageing. The US National Institute on Aging gives some examples of what is considered normal forgetfulness in old age, and dementia disease. You can refer to these above. For example, it is normal for an ageing person to forget which word to use from time-to-time, but difficulties having conversation would be more indicative of dementia. Katie Puckering, Head of Alzheimer's Research UK's Information Services team, previously told The Sun: 'We quite commonly as humans put our car keys somewhere out of the ordinary and it takes longer for us to find them. 'As you get older, it takes longer for you to recall, or you really have to think; What was I doing? Where was I? What distracted me? Was it that I had to let the dog out? And then you find the keys by the back door. 'That process of retrieving the information is just a bit slower in people as they age. 'In dementia, someone may not be able to recall that information and what they did when they came into the house. 'What may also happen is they might put it somewhere it really doesn't belong. For example, rather than putting the milk back in the fridge, they put the kettle in the fridge.'

Is a solar eclipse happening in August? Yes, but not next month
Is a solar eclipse happening in August? Yes, but not next month

The Independent

timean hour ago

  • The Independent

Is a solar eclipse happening in August? Yes, but not next month

Reports of a solar eclipse on 2 August have been spreading across social media, supported by stories in several news outlets. But while excitement has centred on the celestial spectacle taking place next month, hopeful sky gazers will actually have to wait another two years to witness it. The total solar eclipse will see the Moon pass directly in front of the Sun in 2027, casting a shadow across large parts of Europe, North Africa and the Middle East. Another total solar eclipse will happen before that, on 12 August 2026, passing over Western Europe. The path of totality for the 2027 eclipse, where the Sun will be completely blocked from view, begins in the North Atlantic before arcing over the Mediterranean and finishing in the Indian Ocean. Luxor in Egypt sits in the middle of the path, which will see the longest totality of six minutes and 23 seconds. The last time a totality lasted this long on land was in 1991 – and the next time will not be until the year 2114. Nasa advises anyone hoping to see the solar eclipse to choose a viewing location based on the weather, rather than how close it is to the path of totality. 'It's much more important to watch the weather forecasts a day or two before the eclipse and choose a location with the best chance of a cloud-free sky during the eclipse,' the US space agency wrote in a blog post. 'Good weather is the key to successful eclipse viewing - better to see a shorter eclipse from clear sky that a longer eclipse under clouds.' Anyone not directly under the path of totality will still be able to see a partial eclipse on 2 August 2027, which will be visible from as far north as Iceland and as far south as Madagascar.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store